This Report features up to a ten-year record of the equity Price history for 4SC AG. Tabular results include the High, Low and Closing price for the quarter. There is also a calculation of percentage change in price for both Quarterly and Annual periods. Price values are adjusted for stock splits and dividends.
4SC AG. The Group's Principal activity is to develop new drug candidates for the treatment of patients suffering from diseases with high medical needs. It uses cheminformatics-based technology platform for development of drugs. The group operates in two divisions: Drug Discovery and Development and Collaborative Business.
Not the Report you are looking for?Click here for more browsing options.
* If a currency is not selected, the report will be delivered in the local currency of the company ** Full access limits users to 500 reports per month
Web site and selected data copyright 2008 The Winthrop Corporation. All rights reserved. Selected data copyright 2008, "Worldscope/Disclosure, L.L.C., a Primark affiliate." All rights reserved.
